Skandinaviska Enskilda Banken Ab (Publ) Immunity Bio, Inc. Call Options Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $24.3 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IBRX
# of Institutions
289Shares Held
132MCall Options Held
2.53MPut Options Held
3.02M-
Vanguard Group Inc Valley Forge, PA27.7MShares$55.3 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY12.8MShares$25.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$22.8 Million0.0% of portfolio
-
State Street Corp Boston, MA11.3MShares$22.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$17.5 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $801M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...